Reprod Biol. 2025 Mar;25(1):100968.doi: 10.1016/j.repbio.2024.100968. Epub 2024 Dec 16. Metformin-induced RBMS3 expression enhances ferroptosis and suppresses ovarian cancer progression 二甲双胍诱导的RBMS3表达可增强铁死亡并抑制卵巢癌进展
Adv Sci (Weinh). 2025 Mar 7:e2416536.doi: 10.1002/advs.202416536. Identification of NIBAN2-Regulated RUNX2 Alternative Splicing Presents Novel Strategies for Antagonizing Osteoporosis NIBAN2调控的RUNX2选择性剪接的鉴定提出了对抗骨质疏松症的新策略 (IF:15.1).
Elife. 2025 Mar 7:13:RP92419.doi: 10.7554/eLife.92419. PCBP2 as an intrinsic agi ng factor regulates the senescence of hBMSCs through the ROS-FGF2 signaling axis PCBP2作为一种内在的激动因子，通过ROS-FGF2信号轴调节hBMSCs的衰老
Histol Histopathol. 2025 Mar 6:18899.doi: 10.14670/HH-18-899. Online ahead of print. TGAX promotes Th17-cell differentiation and drives pathogenesis in pediatric ulcerative colitis TGAX促进Th17细胞分化并驱动儿童溃疡性结肠炎的发病机制
Molecules. 2025 Mar 6;30(5):1187.doi: 10.3390/molecules30051187. Forsythiaside A Reduces Acetaminophen Hepatotoxic Metabolism by Inhibiting Pregnane X Receptor 连翘苷A通过抑制孕烷X受体降低对乙酰氨基酚肝毒性代谢
Cell Death Discov. 2025 May 5;11(1):217.doi: 10.1038/s41420-025-02401-3. IFN-γ could induce ferroptosis in keloid fibroblasts by inhibiting the expression of serpine2 IFN-γ通过抑制丝氨酸蛋白酶2的表达诱导瘢痕疙瘩成纤维细胞铁下垂 (IF:6.1).
Stem Cell Res Ther. 2025 May 1;16(1):216.doi: 10.1186/s13287-025-04300-x. DSUP modified mesenchymal stem cells exert significant radiation protective effect by enhancing the hematopoietic niche DSUP修饰的间充质干细胞通过增强造血生态位发挥显著的辐射防护作用
Aquac Nutr. 2025 Feb 26:2025:9406490.doi: 10.1155/anu/9406490. eCollection 2025.Branched-Chain Amino Acids Target miR-203a/fosb Axis to Promote Skeletal Muscle Growth in Common Carp (Cyprinus carpio) 支链氨基酸靶向miR-203a/fosb轴促进鲤鱼骨骼肌生长
J Invertebr Pathol. 2025 Feb 21:210:108289.doi: 10.1016/j.jip.2025.108289. Characterization and functional analysis of the small heat shock protein HSP19.5 in Bombyx mori in response to Nosema bombycis infection 小分子热休克蛋白HSP19.5的特性和功能分析对家蚕微孢子虫感染的反应
Cell. 2025 Feb 20;188(4):1119-1136.e23.doi: 10.1016/j.cell.2024.12.010. Epub 2025 Jan 17. Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients 癌症难治性患者超急性排斥反应工程溶瘤病毒介入临床试验 (IF:66.850).
